Small Extracellular Vesicle miRNAs as Predictive Biomarkers for Immunochemotherapy Efficacy in Extensive-stage Small Cell Lung Cancer

RecruitingOBSERVATIONAL
Enrollment

38

Participants

Timeline

Start Date

January 3, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Interventions
COMBINATION_PRODUCT

EC/EP + ICIs

Collect blood samples from patients with small cell lung cancer before receiving immunotherapy combined with chemotherapy.

Trial Locations (1)

200030

RECRUITING

Shanghai Chest Hospital, Shanghai

All Listed Sponsors
lead

Shanghai Chest Hospital of Shanghai Jiao Tong University

OTHER